Global Market for Medical Devices, 5th Edition
The fifth edition of Kalorama Information’s Global Market for Medical Devices presents an industry adjusting to challenges of reimbursement reductions and new taxes. New product innovations and mergers were part of the strategies companies adapted in order to compete. In the United States, the second year of collections on the medical device tax began, and the report describes the impact. In Europe as well as the United States, reimbursement challenges and the threat of new legislation loom. Emerging markets again helped to boost revenues elsewhere, but even some emerging nations saw growth rate reductions. Device manufacturers responded by boosting innovation and technology, finding new markets, and buying each other.
As part of the market analysis in this report, the following is included:
Size and Forecast of the World Market for Medical Devices
Index of 15 Important Medical Device Players: Performance 2012-2013, International Sales Focus, R&D Spending
Regional Breakouts for US, Europe, Asia and Rest of World Regions
Segment Markets (Catheters, GI, Orthopedic, MIS, Dialysis, Patient Monitoring, MRI, Ultrasound, X-Ray, Medical Beds, IOLs, Infusion Pumps, Stents, Respiratory, Point of Care Testing Devices, Other)
Country Markets for US, UK, Australia, Brazil, Japan, Germany, China, Italy, France
36 Profiles of Key Medical Device Companies
Mergers and Acquisitions in the Device Market
New Product Launches, 2013
Impact of US Medical Device Taxes
Company Market Share
Kalorama Information considers estimates of manufacturer revenues the most important and valid methodology for business planning. In many of the largest device markets, Kalorama Information has already conducted studies and has examined manufacturer revenue estimates, rendering the total market visible.
This report was assembled using data from Kalorama Information’s previous medical device reports. Primary and secondary research was used. Research into company annual reports, trade publications, government and medical literature was used as a foundation. Interviews with executives at medical device companies were conducted and are the key source of estimates.